Clinical trial

A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes

NCT04150107

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-10-17

PhasePHASE2

Study timeline

Study start (actual)2019-10-17Date precision: day

Registry last updated2022-06-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

ORMD-0801 Treatment ADRUG

ORMD-0801 Treatment BDRUG

PlaceboOTHER

Sponsors & collaborators

Oramed, Ltd.lead sponsor

Integriumcollaborator

Mapped research locations

TustinCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04150107 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.